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Summary.-I.v. injection of Corynebacterium parvum (CP) into C57BL and BALB/c
mice caused profound coagulation changes, featuring thrombocytopenia, decreased
fibrinogen, increased fibrin/fibrinogen degradation products, and a concomitant
microangiopathic haemolytic anaemia. These changes were greatest on the 9th day
after CP, with recovery by Day 21. I.p. injection caused similar effects but s.c. injec-
tion was ineffective. Radiolabelled-platelet kinetics and distribution after i.v. CP
indicated disseminated intravascular coagulation with rapid fibrinolysis; EACA
treatment exacerbated the thrombosis. The coagulopathy correlated with hepato-
splenomegaly, and both were dose dependent. Splenectomy did not affect the coagulo-
pathy, but indomethacin totally abrogated the changes, suggesting that prostaglandin
biosynthesis is involved in the pathogenesis.
COR?YNEBA TERIUM PARVUIM (CP) in-
hibits the growth and dissemination of a
variety of experimental tumours (Halpern
et al., 1966; Woodruff & Boak, 1966;
Smith & Scott, 1972; Proctor et al., 1973;
Sadler & Castro, 1976). Given systematic-
ally, it causes non-specific stimulation of
the reticulo-endothelial system (Halpern
et al., 1963) which is regarded as the major
mechanism of the anti-tumour action
(Jones & Castro, 1977; Milas & Scott,
1978).
Previously our group has shown that
i.v. CP causes thrombosis in hepatic,
pulmonary and splenic blood vessels in
mice, and it was concluded that CP in-
duced disseminated intravascular coagu-
lation (Lampert et al., 1977). This assump-
tion was supported by a subsequent study
which showed prolonged thrombocyto-
penia after i.v. CP (Jones et al., 1977).
The present investigations were designed
to elucidate the kinetics and mechan-
isms of the CP-induced coagulopathy in
itilice.
MATERIALS AND METHODS
Anintalls.-Age-matched female C57BL/10
ScSn and BALB/c mice, obtained from Olac
(Southern) Ltd., were used.
Corynebacteriumni parvum.-A formalin-
killed suspension of CP (Welleome strain
CN6134, 7 mg dry weight/ml) wAas given at a
dose of 350 ,ug. In one experiment this dose
was compared to a low-er dose of 70 I-g. CP
w\as injected i.v., i.p. or s.c.
Handling of blood and tiss8es. Blood was
collected by cardiac puncture during ether
anaesthesia. Two samples were taken from
each mouse, the first added to 3 80' sodium
citrate (1 in 10) and the second to trace
amounts of topical thrombin and s-amino-
caproic acid. Livers and spleens were removed
and weighed.
Blood tests. Platelet counts on citrated
blood were performed by the method of
Brecher & Cronkite (1950). Blood films were
made and the haematocrit estimated by
standard techniques.
Prothrombin time, activated paitial throm-
boplastin time and fibrinogen level, were
(letermined by established micro-techniques
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Fibrin/fibrinogen degradation products
(FDP) were determined bythe staphylococcal
clumping test (Hawiger et al., 1970).
Platelet volume distribution was evaluated
electronically by a Coulter Counter ZBI in
connection with a Channelyser.
Platelet turnover and distribution.-Blood
from 45 age- and sex-matched syngeneic
donor mice was mixed 1 in 5 with acid-
citrate-dextrose (ACD). Platelets were separ-
ated by differential centrifugation, labelled
with 51chromium (Dacie & Lewis, 1975) and
0-2 ml ofthe suspension was injected i.v. into
each of 90 mice.
There were 3 groups of recipients: an un-
treated control group, a group given 350 ug
of CP i.v. 2 days earlier, and a group given
350 ,g of CP i.v. 7 days earlier. Ten animals
from each group were killed and sampled 6.
13 and 22 h after platelet injection.
Blood was collected by cardiac puncture
and weighed. Lungs, livers, spleens and
kidneys were excised and immediately
weighed. The radioactivity of the tissues was
determined in a conventional y-scintillation
counter. Activity was expressed as ct/min
both in the whole organ and per mg.
Splenectomy.-In one study mice were
splenectomised 4 weeks before CP injection.
6-aminocaproic acid (EACA).-EACA
(Kabi Vitrum Ltd) was administered imme-
diately before CP as a single i.p. injection of
300 mg/kg body weight, and given thereafter
in the drinking water at a concentration of
4 g/l.
Indomethacin. - Indomethacin (Merck,
Sharp and Dohme) was dissolved in a small
volume of ethanol, diluted to the required
concentration with normal saline and adjus-
ted to a pH of 7-4. Treatment was started
immediately before CP at a. dose of 100 Mug
in 0-2 ml given i.p. and contmiued twice daily
for 2 days. Thereafter a single daily dose of
50 ,g was given.
Statistics.-Sets of results were compared
by the t test for 2 samples.
RESULTS
Intravenous CP.-350 ug of CP injected
i.v. into C57BL mice caused a coagulo-
pathy (Table I) characterized by severe
thrombocytopenia, a significant decrease
in plasma fibrinogen, and a significant
increase of serum fibrin/fibrinogen degra-
dation products (FDP). There were minor
changes in the prothrombin time and
activated partial thromboplastin time.
Changes were greatest on the 9th day after
CP, with recovery by Day 21. There was
an accompanying anaemia, and on the 7th
day many fragmented red cells were seen
on the blood films. On the 7th day the
mean platelet corpuscular volume was
significantly greater than the controls
(8.20 + 0-68 fl compared to 6-54 + 0-55 fl,
P <0.05).
The effects of 350 Mg of CP injected i.v.
were compared with those of 70 ug. The
changes in spleen weight and number of
peripheral-blood platelets are shown in
Fig. 1. Liver weight followed the same
trend as the spleen. Changes were dose
dependent, and the development of
hepatosplenomegaly correlated with
thrombocytopenia.
BALB/c mice given 350 Mg of CP i.v.
also developed marked hepatospleno-
megaly, and experienced a severe coagulo-
pathy identical to that in C57BL mice.
I.p. and s.c. CP (Table II).-I.p. in-
TABLE L.-Effect of 350 ug CP injected i.v. on Day 0 onplatelet count, plasmafibrinogen,
fibrinogen-degradationproducts (FDP),prothrombintime (PT), activatedpartialthrombo-
plastin time (APTT) andpacked cell volume (POV)
Control Day 7 Day 9 Day 12 Day 21
Numberofmice: 12 6 6 6 6
Platelet count (109/1) ±s.d. 667+47 203 + 56** 94+27** 317+42** 555+46** Fibrinogen (md/dl) s.d. 265 +64 129+ 105* 58+ 16** 93+40** 208+87
FDP (titre) +s.d. 4-7+ 7-1 68+26-8 145+ 105* 20+ 12-2
PT (sec) ±s.d. 8-6+1-0 11.2+ 1.6* 10.3+4.5* 9-0+1-2 10-0+ 1-0
APTT (sec) ±s.d. 40-1+3-6 33.3 +3.7* 37-5+9 38-2+3-5 45-8+10-1
PCV (%)±s.d. 43+1 28+5** 27+3** 34+2** 42+2
Significance against control *P< 01 **P <0-001.
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TABLE II. Effect of 350 pg CP injected i.p. or s.c. on Day 0 on platelet count and plasma
fibrinogen
Control
Number ofmice: 10
I.p. Platelet count (109/1) + s.d.
Fibrinogen (mg/dl) + s.d.
S.c. Platelet count (109/l)+s.d.
Fibrinogen (mg/dl) + s.d.
1036 + 194
165 + 50
1036 + 194
165 + 50
Day 7
5
646 + 311*
172+45
824 + 200
204 + 56
Day 12
5
488 + 91**
82+ 42
1190+ 167
224 + 45
Significance against control: *P < 0-01, **P < 0-001.
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TABLE III.-The effect of 350 lg of CP on spleen weight, liver weight and radioactivity in
spleen and liver 22 h after i.v. injection of 51Cr platelets
Spleen Liver
I_
Organ ct/min
No. weight (mg) whole organ
Group mice (mean +s.d.) (mean + s.d.) (I
Control 10 100+19 7214 + 605
Day 2 after CP 10 180+ 34** 10080+ 2099*
Day 7 after CP 10 315+82** 6843+ 1967
Significance against control: *P < 0-01, **P < 0 001.
ct/min/mg
mean+s.d.
74+13
57+12
23+8**
Organ
weight (mg)
.) (mean+s.d.)
829+ 155
1077 + 197
1695+ 344*
TABLE IV. The effects of splenectomy, 6-aminocaproic acid and indomethacin treatments
on the coagulation changes seen 7 days after i.v. injection of 350 ,ug CP
Platelet
No. count Fibrinogen
Treatment mice (109/1) + s.d. (mg/dl) + s.d.
Control 15 1061+ 148 182+ 68
CP 15 172+111** 104+ 74*
CP +splenectomy 5 151 + 25** 140 + 32
CP +t-aminocaproic acid 5 161 + 33** 58+ 21*
CP +indomethacin 5 960+ 85 255 + 117
Significance against control: *P < 0-01, **P < 0-001.
activity in their spleens than did controls.
There was a minor non-significant rise in
radioactivity in livers of mice 2 days after
CP which decreased by Day 7. Lung and
kidney were also examined and contained
little radioactivity.
Treatment.-Various treatments were
given in an attempt to alter the coagulo-
pathy after i.v. CP (Table IV).
Splenectomy failed to protect against
coagulopathy. EACA-treated animals had
enhanced coagulopathy, with lowered
fibrinogen and increased thrombosis on
histological examination. Indomethacin
totally abrogated the coagulation changes.
Splenectomy, EACA and indomethacin
treatments in normal mice had no effect
on the measured variables.
DISCUSSION
CP has been shown to decrease the
number of peripheral-blood platelets
(Jones et al., 1977) and we have now
demonstrated changes in the plasmatic
coagulation system which parallel this
thrombocytopenia. There was a marked
decrease of plasma fibrinogen, an increase
of serum fibrin/fibrinogen degradation
products (FDP) and minor changes in the
prothrombin and activated partial throm-
boplastin times. These findings indicate
disseminated intravascular coagulation
(DIC). The concomitant appearance of
many fragmented red cells associated with
anaemia suggests microangiopathic haem-
olytic anaemia, a syndrome considered to
be a consequence of intravascular fibrin
deposition (Bull & Kuhn, 1970). This
explanation of the anaemia following CP
would be additional to mechanisms pre-
viously described, i.e. enhanced phago-
cytosis and destruction of erythrocytes by
the CP-stimulated RES (Cox & Keast,
1974; McBride et al., 1974) and CP-
induced autoantibody against red cells
(McCracken et al., 1971).
There was no evidence of failure of
platelet production, since there was no
marrow toxicity (unpublished data) and
because the appearance of larger platelets
indicated young platelets entering the
circulation. This suggested the cause of
the thrombocytopenia to be increased
peripheral platelet destruction as was con-
firmed by platelet turnover studies. We
considered that the hepatomegaly and
splenomegaly might be the sites of this
ct/min
whole organ
(mean +s.d.)
6749+ 1968
10519+ 1889*
8762+ 1877
ct/min/mg
(mean +s.d.)
8+2
10+3
5+2
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increased platelet destruction. When
allowance was made for the 2-fold increase
in liver weight and 3-fold increase in
spleen weight by the 7th day after i.v.
CP, the relative uptake of radioactive
platelets by these organs was less than the
controls. We found no evidence of active
sequestration or passive platelet pooling in
the liver, spleen, lung or kidney, and
splenectomy failed to prevent any of the
coagulation changes. This is surprising
since Lampert et al. (1977) described
thrombi in the liver and spleen of CP-
treated mice, but the discrepancy may be
explained if the thrombi were both pre-
cipitated and removed simultaneously, a
phenomenon well known in experimental
animals after endotoxin injection (Theiss
et al., 1975). Accelerated proteolytic
activity is part of the pathophysiology of
intravascular coagulation, and its occur-
rence is supported by the observation that
animals treated with the anti-fibrinolytic
agent EACA, following injection of CP,
had enhancement of the coagulopathy
with increased thrombosis.
The correlation between hepato-spleno-
megaly and coagulation changes suggests
that these two phenomena might be
mediated by the same mechanism. The
organomegaly is associated with an in-
crease in tissue macrophages (McBride et
al., 1974; Warr & Sljivic, 1974; Maruyama
& Coleman, 1978) and phagocytic activity
(Halpern et al., 1963; Adlam & Scott,
1973). Activated macrophages produce
various unstable metabolites of arachid-
onic acid (Brune et al., 1978) including
thromboxane A2. This factor can cause
intravascular platelet aggregation with
subsequent activation of the coagulation
system, and its release from macrophages
can be inhibited by indomethacin (Brune
et al., 1978). Indomethacin treatment of
animals following i.v. injection ofCP com-
pletely prevented the coagulopathy, in-
dicating that enhanced prostaglandin bio-
synthesis may mediate the coagulation
changes.
When the route of administration was
altered from i.v., we found that i.p. injec-
tion of 350 tg of CP caused similar, but
less pronounced, coagulation changes, and
s.c. injection had no effect. S.c. CP at this
dose has little, if any, anti-tumour action
(Sadler & Castro, 1976) suggesting that
CP given s.c. does not reach the target
macrophages. BALB/c mice injected with
CP also developed a severe coagulopathy,
demonstrating that this CP effect is not
strain specific.
In summary, administration of CP in-
duces a coagulopathy in mice as a conse-
quence of intravascular coagulation with
fibrinolysis. It appears that clot-promoting
material, possibly derived from the macro-
phages, initiates this phenomenon. In-
creased fibrinolytic activity has been
found in cancer patients treated with CP
(Cederholm-Williams et al., 1978) indi-
cating that our findings might be clinically
relevant.
This study was performed in a programme sup-
ported by the EORTC Metastasis Project Group and
by a grant from the Medical Research Council.
H. D. Mitcheson was supported by the Wellcome
Foundation.
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